People in the News
Robert Ragusa has joined Affymetrix as senior vice president of global operations, a spokesperson for the company told BioArray News' sister publication GenomeWeb News last week.
Ragusa joined Affy on June 27. According to the spokesperson, Ragusa will fill a new position created to help the company increase its "attention to supply chain and logistics." He will be charged with overseeing array manufacturing, instrument manufacturing, procurement, facilities and real estate, the spokesperson said.
R. Scott Greer has joined CombiMatrix as an advisor, the company said this week. Greer is the managing director of Numenor Ventures, a life sciences investment and advisory firm. He is the founder and chairman of AbiGenix, where he served as CEO from 1996 to 2002. Greer also served as a director at Illumina, Sirna Therapeutics, and CV Therapeutics.
He holds an MBA from Harvard University and a BA in economics from Whitman College.
Michael Wigler, a cancer researcher at Cold Spring Harbor Laboratory, has been awarded a $100,000 grant from the Miracle Foundation to fund his representational oligonucleotide microarray analysis approach to cancer research.
Miracle, a nonprofit cancer organization, announced the award last month, the third Wigler has received from the body to date. Wigler has been using molecular biology to battle cancer for more than 25 years. He received his PhD from Columbia University in 1978.
Australian antibody array developer Medsaic has appointed Mervyn Thomas as senior biostatistician. Thomas is the founder of bioinformatics consultancy Emphron Informatics. He formerly ran the bioinformatics research program for the division of mathematics and information sciences at Australia's Commonwealth Scientific and Industrial Research Organization. Thomas will continue as CEO of Emphron Informatics, and will work at Medsaic as part of a strategic alliance between the two firms.
Stuart Lacock has been named vice president of North American sales for SciGene, the company said last week.
Lacock most recently served as national sales manager for Continental Laboratory Products, and formerly held sales and sales management positions at Bio-Rad Laboratories, Fisher Scientific, and CPI International. At SciGene Lacock will be charged with selling the company's high-throughput microarray systems to the US and Canadian markets.
The Damon Runyon Cancer Research Foundation has awarded Christine Chung, an assistant professor of medicine in the division of hematology and oncology at Vanderbilt University, a five-year, $750,000 grant, according to a report in the Nashville City Paper.
Chung will be using microarray technology to develop gene expression patterns and biomarkers for diagnosis and treatment of head and neck cancers, according to the report.
Andrew MacDonald has become head of the new microarray technologies division of Genesis Diagnostics, the Littleport, UK-based company said last week. He used to be a manager with Genomics Solutions.
New Product Watch
NanoDrop Technologies last month launched its ND-3300 fluorospectrometer, which is capable of "pushing the sensitivity of nucleic acids and microarray dyes" beyond competitive technologies and provides the "benefits of measuring two picograms of DNA in a two microliter PicoGreen [assay] reaction," according to a statement from the company.
Agilent Technologies last week announced that eArray 3.5, an upgrade from the eArray 3.0 web-based tool it launched earlier this year for designing custom DNA microarrays used in drug discovery, disease studies and basic research.
eArray 3.5 enables the sharing of microarray design information among collaborators or with members of research consortia via secure Internet connections, Agilent said.
The 3.5 upgrade also allows access to catalog array comparative genomic hybridization probes, and has been reconfigured to permit researchers to upload their own aCGH probes into the system. The free tool is available on Agilent's website.
BioGenex last month launched its Xmatrx system, which it describes as being ideal for automation of fluorescent in situ hybridization, in situ hybridization, and immunohistochemistry experiments.
Xmatrx is recommended for use in molecular diagnostics and drug research and development, according to a statement from the company.
Sigma-Aldrich last month launched a mitogen-activated protein kinase (MAPK) antibody array and an antibody array for protein kinase C (PKC) expression in cell or protein extracts, the company said.
The company also introduced its Panorama Ab Microarray — MAPK & PKC Pathways Kit, which it recommends for "studying protein expression in cell or tissue extracts" and said is "compatible with various species including human, mouse, and rat."